上海市第十人民医院，又名同济大学附属第十人民医院，为一个机构两块牌子，是位于上海市静安区延长路301号的一所综合性三级甲等医院，属上海市卫生局管辖，是同济大学的附属医院。原名上海铁路局中心医院，前身为位于靶子路的始建于1910年的沪宁铁路医院。

During the past decade, Shanghai Tenth People's Hospital conducted 132 clinical trials. In the 10-year time frame, 132 clinical trials started and 7 clinical trials were completed, i.e. on average, 5.3% percent of trials that started reached the finish line to date. In the past 5 years, 77 clinical trials started and 6 clinical trials were completed. i.e. 7.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shanghai Tenth People's Hospital" #1 sponsor was "Shanghai 10th People's Hospital" with 71 trials, followed by "Shanghai Juncell Therapeutics" with 6 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Shen Qu" with 4 trials sponsored and "Eli Lilly and Company" with 4 trials sponsored. Other sponsors include 60 different institutions and companies that sponsored additional 64 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shanghai Tenth People's Hospital" #1 collaborator was "Shanghai 10th People's Hospital" with 16 trials as a collaborator, "Massachusetts General Hospital" with 4 trials as a collaborator, "First Affiliated Hospital, Sun Yat-Sen University" with 3 trials as a collaborator, "Nanfang Hospital of Southern Medical University" with 3 trials as a collaborator and "The First Affiliated Hospital of Zhengzhou University" with 3 trials as a collaborator. Other collaborators include 93 different institutions and companies that were collaborators in the rest 94 trials.

According to Clinical.Site data, the most researched conditions in "Shanghai Tenth People's Hospital" are "Atrial Fibrillation" (8 trials), "Polycystic Ovary Syndrome" (7 trials), "Coronary Artery Disease" (5 trials), "Effects of Immunotherapy" (5 trials) and "Treatment Side Effects" (5 trials). Many other conditions were trialed in "Shanghai Tenth People's Hospital" in a lesser frequency.

Most popular intervention types in "Shanghai Tenth People's Hospital" are "Drug" (64 trials), "Device" (23 trials), "Other" (22 trials), "Procedure" (19 trials) and "Biological" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Probiotics" (4 trials), "Aflibercept" (3 trials), "Cisplatin" (3 trials) and "Faricimab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Shanghai Tenth People's Hospital" are 135 trials for "All" genders, 13 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are 67 active trials in "Shanghai Tenth People's Hospital". 6 are not yet recruiting, 55 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 32 completed trials in Shanghai Tenth People's Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Shanghai Tenth People's Hospital, 8 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 21 trials, and there were also 35 trials that are defined as “Not Applicable".

Shanghai Tenth People's Hospital has several departments that took part in Clinical trials: "Shanghai Pulmonary Hospital" - 7 trials